Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155699 · ClinicalTrials.gov registry record · NA
Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis
A NA study of Attenuated Psychosis Syndrome, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02155699 is a NA study of Attenuated Psychosis Syndrome that has completed, run by University of Colorado, Boulder. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02155699, a NA study of Attenuated Psychosis Syndrome, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to test the feasibility and effectiveness of cardiovascular exercise in promoting brain health and improving related symptoms (e.g., hearing sounds that are not there, feeling emotionally detached from self and others), cognitive difficulties (troubles with memory and learning), and every day social-occupational functioning in youth at imminent risk for developing a psychotic disorder such as schizophrenia. Understanding how exercise may protect or improve the health of a brain area that is implicated as a major contributing factor to the onset of psychosis may lead to a path-breaking new intervention that does not suffer from many of the side effects, costs, and other barriers that characterize treatments that are currently available for this group. Because a significant portion of high-risk youth go on to develop a psychotic disorder in a short period, intervening at this stage may help to improve the clinical course and ultimately prevent the onset of a devastating and prevalent mental illness.
Conditions Studied
Interventions
- BEHAVIORAL Exercise 1
- BEHAVIORAL Exercise 2
Study Locations (1)
Colorado
- ADAPT Program - Boulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-07 |
| Est. Completion | 2022-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155699
The ClinicalTrials.gov registry entry for NCT02155699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attenuated Psychosis Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Exercise 1 is the first listed.
NCT02155699 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT02155699 about?
NCT02155699 is a clinical study titled "Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis". The goal of this proposal is to test the feasibility and effectiveness of cardiovascular exercise in promoting brain health and improving related symptoms (e.g., hearing sounds that are not there, feeling emotionally detached from self and others), cognitive difficulties (troubles with memory and le...
What is the current status of trial NCT02155699?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-07. Estimated completion is 2022-07.
What conditions does trial NCT02155699 study?
This clinical trial studies the following conditions: Attenuated Psychosis Syndrome.
What interventions are being tested in trial NCT02155699?
The interventions under investigation include: Exercise 1 (BEHAVIORAL), Exercise 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02155699?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02155699 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.